The artificial intelligence (AI)-enabled Viz™ Vascular Suite reportedly allows automated detection of vascular conditions, shown on computed tomography (CT) and other imaging modalities, and facilitates timely triage among interdisciplinary teams.
An emerging artificial intelligence (AI) software, which can be utilized with multiple imaging modalities, may enhance the assessment and timely care coordination for vascular conditions, including aortic dissection and pulmonary embolism.
The recently launched Viz Vascular Suite can be utilized with a variety of imaging modalities, including computed tomography (CT) and echocardiography, to provide automated analysis of suspected vascular conditions, according to the software’s manufacturer Viz.ai.
After a vascular condition has been identified, Viz.ai said the Viz Vascular Suite software app sends alerts and patient imaging scans via HIPAA-compliant means to the mobile devices of providers. Philip Batista, M.D., emphasized the ability of the Viz Vascular Suite to foster timely notification and interdisciplinary care for patients with serious vascular conditions.
“When Viz identifies an abnormal scan, it quickly notifies the appropriate specialists regardless of their location, facilitating seamless communication via mobile application,” noted Dr. Batista, an assistant professor of surgery and associate program director of Vascular and Endovascular Surgery Residency at the Cooper Medical School of Rowan University in Camden, N.J. “We’ve been using the Viz software for the last several months and have seen improvements in patient care across our institution.”
(Editor’s note: For related articles, see “AI-Powered Algorithm May Enhance CT Assessment of Aortic Dissection,” “Pie Medical Imaging Launches AI-Powered Echocardiography Platform” and “FDA Clears AI-Powered Echocardiography Platform for Detecting Heart Failure with Preserved Ejection Fraction.”)
Comparative AI Study Shows Merits of RapidAI LVO Software in Stroke Detection
February 6th 2025The Rapid LVO AI software detected 33 percent more cases of large vessel occlusion (LVO) on computed tomography angiography (CTA) than Viz LVO AI software, according to a new comparative study presented at the International Stroke Conference (ISC).
New CT Angiography Study Shows Impact of COVID-19 on Coronary Inflammation and Plaque
February 5th 2025Prior COVID-19 infection was associated with a 28 percent higher progression of total percent atheroma volume (PAV) annually and over a 5 percent higher incidence of high-risk plaque in patients with coronary artery lesions, according to CCTA findings from a new study.
Computed Tomography Study Assesses Model for Predicting Recurrence of Non-Small Cell Lung Cancer
January 31st 2025A predictive model for non-small cell lung cancer (NSCLC) recurrence, based on clinical parameters and CT findings, demonstrated an 85.2 percent AUC and 83.3 percent sensitivity rate, according to external validation testing in a new study.